Recent advances in peptide based therapies for obesity and type 2 diabetes ScienceDirect CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes New England Journal of Medicine GLP 1 Weight Loss Drugs: How Semaglutide & Tirzepatide Redefine Obesity Care Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how Tirzepatide (5mg 10mg 15mg 20mg 30mg) Cagrilintide, an amylin analog, enhances the weight loss effects of semaglutide or tirzepatide by slowing gastric emptying, suppressing glucagon, and reducing appetite. It works synergistically with